Literature DB >> 8458380

The transcription factor Pit-1/GHF-1 is expressed in hemopoietic and lymphoid tissues.

M Delhase1, P Vergani, A Malur, E L Hooghe-Peters, R J Hooghe.   

Abstract

The expression of the Pit-1/GHF-1 transcription factor (hereafter Pit-1), which controls the expression of growth hormone (GH) and prolactin (PRL) in the pituitary gland, has been documented in human and rat hemopoietic and lymphoid tissues and cell lines. Pit-1 mRNA was detected by in situ hybridization in about 1% of rat bone marrow cells and in the spleen red pulp and marginal zone. Pit-1 was also expressed in human tonsils (mantle zone), in the thymus (rat and human, non-lymphoid cells), in lipopolysaccharide-stimulated rat peritoneal cells and in non-hepatocyte cells in the liver (rat and human). A detailed investigation of the rat spleen showed a very similar distribution for Pit-1, GH and PRL mRNA and Pit-1, GH and PRL proteins (detected by immunocytochemistry). Using polymerase chain reaction followed by Southern hybridization, the expression of Pit-1 could be confirmed in human and rat spleen, bone marrow and thymus. HL60 and RAJI leukemic cells were also positive. The sequence of fragments amplified from rat spleen and from human bone marrow completely matched published sequences of rat and human pituitary Pit-1, respectively. Expression of GH and PRL in lymphoid tissues has been documented. The straightforward hypothesis would therefore be that Pit-1's main function in lymphoid tissues is controlling GH and PRL expression, as in the pituitary gland. GH and PRL may be hemopoietic and lymphoid growth and differentiation factors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8458380     DOI: 10.1002/eji.1830230428

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

Review 1.  Growth hormone. A paracrine growth factor?

Authors:  S Harvey; K L Hull
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

2.  CEBPD suppresses prolactin expression and prolactinoma cell proliferation.

Authors:  Yunguang Tong; Jin Zhou; Jun Mizutani; Hidenori Fukuoka; Song-Guang Ren; Arthur Gutierrez-Hartmann; H Phillip Koeffler; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2011-10-06

3.  Immunohistochemical and in situ hybridization detection of growth-hormone-producing cells in human thymoma.

Authors:  L Lauriola; N Maggiano; F G Serra; S Nori; M L Tardio; A Capelli; M Piantelli; F O Ranelletti
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

4.  Multiplex selection technique (MuST): an approach to clone transcription factor binding sites.

Authors:  G N Nallur; K Prakash; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

5.  Expression of the growth hormone gene in immune tissues.

Authors:  C L Render; K L Hull; S Harvey
Journal:  Endocrine       Date:  1995-10       Impact factor: 3.633

Review 6.  Prolactin as an autocrine/paracrine factor in breast tissue.

Authors:  C V Clevenger; T L Plank
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

7.  Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasis.

Authors:  Isabel Ben-Batalla; Samuel Seoane; Tomas Garcia-Caballero; Rosalia Gallego; Manuel Macia; Luis O Gonzalez; Francisco Vizoso; Roman Perez-Fernandez
Journal:  J Clin Invest       Date:  2010-11-08       Impact factor: 14.808

8.  Both pituitary and placental growth hormone transcripts are expressed in human peripheral blood mononuclear cells (PBMC).

Authors:  L Melen; G Hennen; R P Dullaart; E Heinen; A Igout
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

9.  The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors.

Authors:  I Ben-Batalla; S Seoane; M Macia; T Garcia-Caballero; L O Gonzalez; F Vizoso; R Perez-Fernandez
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

10.  POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15).

Authors:  Susana Lisboa; Nuno Cerveira; Susana Bizarro; Cecília Correia; Joana Vieira; Lurdes Torres; José M Mariz; Manuel R Teixeira
Journal:  Mol Cancer       Date:  2013-01-18       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.